Seoul, Feb 27 As many as 18,500 beneficiaries were inoculated with the Covid-19 jabs on the first day of the vaccination drive across South Korea, a government agency said on Saturday.
According to the Central Disaster and Safety Countermeasure Headquarters, 18,489 people across the country got their first shots of the two-dose AstraZeneca vaccine on Friday, Yonhap reported.
"On Friday, 18,489 medical workers, healthcare workers and nursing home patients received the AstraZeneca vaccine at community health centres and 213 nursing facilities in 17 metropolitan cities and provinces as planned," said Jeon Hae-cheol, Minister of the Interior and Safety, in an agency meeting.
The Minister added that there have been no reports of specific adverse reactions from vaccine recipients, except for mild symptoms, such as headaches and fever.
The first day tally of vaccination represents 6.39 per cent of 289,480 healthcare workers and patients under 65 years of age who had agreed to the jabs. It also accounts for 0.04 per cent of the nation's population of 52 million.
By region, Gyeonggi Province, which surrounds Seoul, accounted for 3,532 of the Day 1 vaccine recipients, followed by 3,072 in Gwangju and 1,922 in the capital.
The administering of Pfizer's vaccine also began at the National Medical Centre in Seoul on Saturday.
The first shipment of 58,500 doses of Pfizer's vaccine arrived in Korea on Friday and an additional 500,000 doses are due to arrive at the beginning of the third week of March.
About 300 medical and other workers 199 from the National Medical Centre and 101 from other hospitals specialising in the treatment of Covid patients are to receive the Pfizer vaccine.
The nation's first recipient of the Pfizer vaccine was a 51-year-old sanitation worker of the National Medical Centre, named Chung Mi-kyeong, who got the shot at 9:04 a.m.(local time), said government officials.
( With inputs from IANS )
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor